Provenienza dei contatti di primo grado di Xuedong Liu
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO.
7
| Holding Company | Biotechnology | 7 |
Vesicle Therapeutics, Inc.
Vesicle Therapeutics, Inc. BiotechnologyHealth Technology Vesicle Therapeutics, Inc. is a biotechnology company that operates in the field of life sciences. The company is based in Niwot, CO. The CEO of the company is Donna Peak.
1
| Holding Company | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Xuedong Liu tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
DOVER CORPORATION | Industrial Machinery | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | Miscellaneous Commercial Services | Director/Board Member | |
Core Brewing & Distilling Co. LLC
Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK. | Beverages: Alcoholic | Director/Board Member | |
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology KromaTid, Inc. provides products and services for mutation detection and disease diagnosis. Its services include high resolution screening of individual genes to the entire genome, sequence, location and orientation from a single assay, cost effective discovery of inversions and translocations, rapid assay development and data delivery. The company was founded by Andrew F. Ray, Susan M. Bailey, Michael Cornforth, Edwin Goodwin, and Joel S. Bedford in 2007 and is headquartered in Longmont, CO. | Pharmaceuticals: Major | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Sanford C. Bernstein & Co. LLC
Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Sanford C. Bernstein & Co. LLC is a registered broker-dealer headquartered in New York City. The firm was founded in 1967 and is a subsidiary of Alliance Capital Management LLC, ultimately held by Equitable Holdings, Inc. (NYSE: EQH). Sanford C. Bernstein & Co. provides trading and executions services to their clients. | Investment Banks/Brokers | Analyst-Equity | |
The University of Chicago | College/University | Masters Business Admin | |
Yale University | College/University | Corporate Officer/Principal | |
The University of Colorado | College/University | Corporate Officer/Principal | |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
The State University of New York | College/University | Undergraduate Degree | |
University of Canterbury | College/University | Doctorate Degree | |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
Bend Research, Inc.
Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Torrey Pines Investment, Inc.
Torrey Pines Investment, Inc. Investment ManagersFinance Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California. | Investment Managers | Private Equity Investor | |
Amgen BV
Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
University of Colorado Boulder | College/University | Undergraduate Degree | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
C4 THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
ClinOne, Inc.
ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Packaged Software | Director of Finance/CFO | |
EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
FRESH TRACKS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Acorn Capital Advisors LLC
Acorn Capital Advisors LLC Investment ManagersFinance Acorn Capital Advisors LLC (Acorn Bioventures) is a venture capital firm founded in the year 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
ELEVATION ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. operates as a biotechnology development company. The company is based in Wayland, MA. The CEO of the company is Frank G. Haluska. | Miscellaneous Commercial Services | Director/Board Member | |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
Cormorantasset Management LP | Corporate Officer/Principal | ||
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | Biotechnology | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Blossom Biosciences Ltd.
Blossom Biosciences Ltd. BiotechnologyHealth Technology Blossom Biosciences Ltd. provides molecular and cell biology research services. The company is based in Hong Kong, Hong Kong. Andrew J. Phillips has been the CEO of the Chinese company since 2021. | Biotechnology | Chief Executive Officer | |
Aleksia Therapeutics, Inc. | Chief Executive Officer | ||
Blossom Biomedicines USA, Inc. | Director/Board Member | ||
Nexo Therapeutics, Inc.
Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 43 |
Svizzera | 3 |
Nuova-Zelanda | 2 |
Corea del Sud | 2 |
Paesi Bassi | 2 |
Settori
Health Technology | 28 |
Consumer Services | 8 |
Finance | 6 |
Commercial Services | 4 |
Producer Manufacturing | 2 |
Posizioni
Director/Board Member | 33 |
Corporate Officer/Principal | 11 |
Director of Finance/CFO | 10 |
Chief Executive Officer | 8 |
President | 7 |
Contatti più connessi
Insiders | |
---|---|
Andrew Phillips | 23 |
R. Carruthers | 15 |
Isaac Manke | 15 |
Nicholas A. Saccomano | 10 |
Anthony D. Piscopio | 7 |
Donna Peak | 2 |
John DeMattei | 1 |
Guobao Zhao | 1 |
- Borsa valori
- Insiders
- Xuedong Liu
- Connessioni Società